CASE REPORT

A 50-year-old male had admitted for further evaluation of large hepatic mass. The hepatic mass was found accidently in ultrasonography. His major symptom was a 7-kg weight loss in one month. No gastrointestinal symptoms were present. He had no history of hypertension or diabetes. The serologic markers for hepatitis were negative. His mother had died due to cholangiocarcinoma. On physical examination of the patient, a spider angioma was detected. In the laboratory tests, aspartate aminotransferase/alanine aminotransferase/alkaline phosphatase were increased at 148/54/1,215 U/L, alpha-fetoprotein (AFP) 166 ng/mL, and carcinoembryonic antigen (CEA) 8.19 ng/mL, but cancer antigen 19-9 was in the normal range at 26.6 U/mL. Computerized tomography (CT) showed a very large multinodular hypoattenuating mass with rim enhancement in the whole left lobe and anterior segment of the right lobe (Fig. 1). Also the common hepatic lymph nodes were increased in size. There was no abnormality in each right of left kidney. On positron emission tomography-CT, a large hypermetabolic mass was seen, encompassing the whole left lobe and the anterior segment of the right lobe (Fig. 2).

Pathologic findings

For diagnostic confirmation, CT-guided needle biopsy was performed. The biopsy cores were composed of hypercellular areas alternating with necrosis and hemorrhage. The cellular lesion showed loosely cohesive tumor cell clusters separated by intermediate fibrous septa. The large round tumor cells showed abundant eosinophilic cytoplasm and eccentric vesicular nuclei with prominent nucleoli (Fig. 3A). Abnormal mitoses were frequent. Mucicarmine staining was negative for abundant cytoplasm. The immunohistochemical stains showed diffuse cytoplasmic-positive staining for cytokeratin (CK) 19 and vimentin (Fig. 3B, C) and focal positivity for epithelial membrane antigen and CK7. The immunohistochemical stains for hepatocyte antigen, alpha-fetoprotein, CK20, CD34, CD117, actin, desmin, S100, and human melanoma black 45 (HMB45) showed no reaction in tumor cells. Also the tumor cells showed partial loss of positivity for integrase interactor-1 (INI-1) (Fig. 3D).

DISCUSSION

MRT is a rare aggressive renal or extrarenal tumor arising in infants and young children. Since Beckwith and Palmer10 first described MRT, a few primary or metastatic liver MRTs have been reported in children.1,4-8 Even after that, primary MRT in the adult liver is very rare. Only one MRT in a young adult has been presented in the liver.9

Generally, primary liver MRTs present as a single voluminous liver mass with no other specific clinical symptoms. On serologic tests, AFP and CEA did not increase in most hepatic MRT patients. Due to voluminous hepatic mass formation and no increased tumor markers such as AFP and CEA, primary liver MRTs should be differentiated from hepatoblastoma, hepatocellular carcinoma, and Ewing's tumor in children, and mass-forming cholangiocarcinoma in adults.

Histologically, loosely cohesive tumor cells had abundant eosinophilic cytoplasm and eccentric vesicular nuclei with prominent nucleoli. These features are characteristic in renal/extrarenal rhabdoid tumors. Ultrastructurally, intracytoplasmic filaments were detected. Immunohistochemically, almost all MRTs show dual positivity for CK and vimentin but a negative reaction for alpha-fetoprotein, CD34, CD117, actin, desmin, S100, and HMB45. Loss of INI-1 protein nuclear expression in MRTs is known to be related to a mutation of the hSNF5/INI1 gene. We conclude that the characteristic histology showing a rhabdoid feature and immunohistochemistry indicating loss of INI-1 protein nuclear expression are essential for the diagnosis of MRT. Also, it seems to be significant that this case is the first primary liver MRT arising in an elderly adult among the reports of extrarenal hepatic MRTs.

REFERENCES

• 1. Katzenstein HM, Kletzel M, Reynolds M, Superina R, Gonzalez-Crussi F. Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue. Med Pediatr Oncol 2003; 40: 199-201. ArticlePubMed
• 2. Lee SY, Kim DC, Rha SH, et al. Extrarenal malignant rhabdoid tumor: a case report. Korean J Cytopathol 1996; 7: 69-74. Article
• 3. Abe T, Oguma E, Nozawa K, et al. Malignant rhabdoid tumor of the liver: a case report with US and CT manifestation. Jpn J Radiol 2009; 27: 462-465. ArticlePubMed
• 4. Clairotte A, Ringenbach F, Laithier V, Aubert D, Kantelip B. Malignant rhabdoid tumor of the liver with spontaneous rupture: a case report. Ann Pathol 2006; 26: 122-125. ArticlePubMed
• 5. Donner LR, Rao A, Truss LM, Dobin SM. Translocation (8;13) (q24.2; q33) in a malignant rhabdoid tumor of the liver. Cancer Genet Cytogenet 2000; 116: 153-157. ArticlePubMed
• 6. Hunt SJ, Anderson WD. Malignant rhabdoid tumor of the liver: a distinct clinicopathologic entity. Am J Clin Pathol 1990; 94: 645-648. ArticlePubMed
• 7. Pogacnik A, Zidar N. Malignant rhabdoid tumor of the liver diagnosed by fine needle aspiration cytology: a case report. Acta Cytol 1997; 41: 539-543. ArticlePubMed
• 8. Ravindra KV, Cullinane C, Lewis IJ, Squire BR, Stringer MD. Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J Pediatr Surg 2002; 37: 1488-1490. ArticlePubMed
• 9. Sibileau E, Moroch J, Teyssedou C, Aubé C. Malignant rhabdoid tumors of the liver: an exceptional tumor in adults: a case report and literature review. Eur J Gastroenterol Hepatol 2011; 23: 104-108. ArticlePubMed
• 10. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer 1978; 41: 1937-1948. ArticlePubMed

Fig. 1

Computed tomography shows a very large hypoattenuating hepatic mass with rim enhancement in the left lobe of the liver.

Fig. 2

Positron emission tomography shows a very large hypermetabolic hepatic mass.

Fig. 3

Loosely cohesive eosinophilic tumor cells with eccentric nuclei (A) show diffuse positive reaction for cytokeratin 19 (B) and vimentin (C) and loss of reactivity in integrase interactor-1 (D).

Figure & Data

References

Citations

Citations to this article as recorded by  

• Primary extrarenal rhabdoid tumour of the liver: a case report and literature review
  M Meyers, P Demetter, A.K. De Roo, M Pezzullo, C Jungels, B Brichard, C De Magnee, R.R. De Krijger, G Verset
  Acta Gastro Enterologica Belgica.2024; 86(4): 555.     CrossRef
• Malignant rhabdoid tumor of the liver in a middle-aged woman: a case report and literature review
  Haikun Ye, Zirong Liu, Yamin Zhang
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Primary Malignant Rhabdoid Tumour of the Liver in Adult Male: a Diagnostic and Therapeutic Challenge
  Sunil Pasricha, Garima Durga, Gurudutt Gupta, Ankush Jajodia, Venkata Pradeep Babu Koyyala, Anila Sharma, Meenakshi Kamboj, Manoj Gupta, Anurag Mehta
  Journal of Gastrointestinal Cancer.2021; 52(2): 738.     CrossRef
• Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
  Wilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, Irene Jimenez, Laetitia Maillot, David Gentien, Benoît Albaud, Walid Chemlali, Christine Galant, Frederique Larousserie, Pascaline Boudou-Rouquette, Amaury Leruste, Celine Chauvin, Zhi Yan Han, Je
  Oncotarget.2017; 8(21): 34245.     CrossRef
• Malignant Rhabdoid Tumor of the Kidney Arising in an Adult Patient
  Varsha Podduturi, Molly M. Campa-Thompson, Xin J. Zhou, Joseph M. Guileyardo
  Baylor University Medical Center Proceedings.2014; 27(3): 239.     CrossRef